Literature DB >> 27650708

Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.

Bryce B Reeve1,2, Molly McFatrich1, Laura C Pinheiro1,2, Meaghann S Weaver3, Lillian Sung4,5, Janice S Withycombe6, Justin N Baker3, Jennifer W Mack7, Mia K Waldron8, Deborah Gibson3, Deborah Tomlinson4, David R Freyer9, Catriona Mowbray10, Shana Jacobs10, Diana Palma9, Christa E Martens1, Stuart H Gold1, Kathryn D Jackson1, Pamela S Hinds8,11.   

Abstract

BACKGROUND: Adverse event (AE) reporting in oncology trials is required, but current practice does not directly integrate the child's voice. The Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is being developed to assess symptomatic AEs via child/adolescent self-report or proxy-report. This qualitative study evaluates the child's/adolescent's understanding and ability to provide valid responses to the PRO-CTCAE to inform questionnaire refinements and confirm content validity. PROCEDURE: From seven pediatric research hospitals, children/adolescents ages 7-15 years who were diagnosed with cancer and receiving treatment were eligible, along with their parent-proxies. The Pediatric PRO-CTCAE includes 130 questions that assess 62 symptomatic AEs capturing symptom frequency, severity, interference, or presence. Cognitive interviews with retrospective probing were completed with children in the age groups of 7-8, 9-12, and 13-15 years. The children/adolescents and proxies were interviewed independently.
RESULTS: Two rounds of interviews involved 81 children and adolescents and 74 parent-proxies. Fifteen of the 62 AE terms were revised after Round 1, including refinements to the questions assessing symptom severity. Most participants rated the PRO-CTCAE AE items as "very easy" or "somewhat easy" and were able to read, understand, and provide valid responses to questions. A few AE items assessing rare events were challenging to understand.
CONCLUSIONS: The Pediatric and Proxy PRO-CTCAE performed well among children and adolescents and their proxies, supporting its content validity. Data from PRO-CTCAE may improve symptomatic AE reporting in clinical trials and enhance the quality of care that children receive.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  adverse events; cancer; cognitive interviews; patient-reported outcomes

Mesh:

Substances:

Year:  2016        PMID: 27650708      PMCID: PMC5301979          DOI: 10.1002/pbc.26261

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  22 in total

1.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-10       Impact factor: 5.725

2.  Agreement between pediatric brain tumor patients and parent proxy reports regarding the Pediatric Functional Assessment of Cancer Therapy-Childhood Brain Tumor Survivors questionnaire, version 2.

Authors:  Hee-Jung Yoo; Young-Shin Ra; Hyeon-Jin Park; Jin-Shei Lai; David Cella; Hee-Young Shin; Dong-Seok Kim
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

3.  Influence of proxy respondents and mode of administration on health status assessment following central nervous system tumours in childhood.

Authors:  A W Glaser; K Davies; D Walker; D Brazier
Journal:  Qual Life Res       Date:  1997-01       Impact factor: 4.147

4.  The missing voice of patients in drug-safety reporting.

Authors:  Ethan Basch
Journal:  N Engl J Med       Date:  2010-03-11       Impact factor: 91.245

5.  PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions.

Authors:  Darren A DeWalt; Heather E Gross; Debbie S Gipson; David T Selewski; Esi Morgan DeWitt; Carlton D Dampier; Pamela S Hinds; I-Chan Huang; David Thissen; James W Varni
Journal:  Qual Life Res       Date:  2015-02-26       Impact factor: 4.147

6.  The measurement of symptoms in children with cancer.

Authors:  J J Collins; M E Byrnes; I J Dunkel; J Lapin; T Nadel; H T Thaler; T Polyak; B Rapkin; R K Portenoy
Journal:  J Pain Symptom Manage       Date:  2000-05       Impact factor: 3.612

7.  Dissociations between implicit and explicit memory in children: the role of strategic processing and the knowledge base.

Authors:  Kristina Murphy; Elinor McKone; Judith Slee
Journal:  J Exp Child Psychol       Date:  2003-02

8.  Nurses provide valuable proxy assessment of the health-related quality of life of children with Hodgkin disease.

Authors:  Robert J Klaassen; Ronald D Barr; Joanna Hughes; Paul Rogers; Ronald Anderson; Paul Grundy; S Kaiser Ali; Rochelle Yanofsky; Oussama Abla; Mariana Silva; Anne-Sophie Carret; Mario Cappelli
Journal:  Cancer       Date:  2010-03-15       Impact factor: 6.860

9.  The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians.

Authors:  Bryce B Reeve; Janice S Withycombe; Justin N Baker; Mary C Hooke; Jessica C Lyons; Catriona Mowbray; Jichuan Wang; David R Freyer; Steven Joffe; Lillian Sung; Deborah Tomlinson; Stuart H Gold; Pamela S Hinds
Journal:  Pediatr Blood Cancer       Date:  2013-01-17       Impact factor: 3.167

10.  Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Jennifer L Hay; Thomas M Atkinson; Bryce B Reeve; Sandra A Mitchell; Tito R Mendoza; Gordon Willis; Lori M Minasian; Steven B Clauser; Andrea Denicoff; Ann O'Mara; Alice Chen; Antonia V Bennett; Diane B Paul; Joshua Gagne; Lauren Rogak; Laura Sit; Vish Viswanath; Deborah Schrag; Ethan Basch
Journal:  Qual Life Res       Date:  2013-07-20       Impact factor: 4.147

View more
  22 in total

1.  Methodological and Ethical Issues in Pediatric Medication Safety Research.

Authors:  Delesha Carpenter; Daniel Gonzalez; George Retsch-Bogart; Betsy Sleath; Benjamin Wilfond
Journal:  Pediatrics       Date:  2017-08-04       Impact factor: 7.124

2.  Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events.

Authors:  Tamara P Miller; Brian T Fisher; Kelly D Getz; Leah Sack; Hanieh Razzaghi; Alix E Seif; Rochelle Bagatell; Peter C Adamson; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2019-04-09       Impact factor: 3.167

3.  Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.

Authors:  Molly McFatrich; Jennifer Brondon; Nicole R Lucas; Pamela S Hinds; Scott H Maurer; Jennifer W Mack; David R Freyer; Shana S Jacobs; Justin N Baker; Catriona Mowbray; Mian Wang; Sharon M Castellino; Allison Barz Leahy; Bryce B Reeve
Journal:  Cancer       Date:  2019-09-25       Impact factor: 6.860

4.  Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.

Authors:  Bryce B Reeve; Molly McFatrich; Laura C Pinheiro; David R Freyer; Ethan M Basch; Justin N Baker; Janice S Withycombe; Lillian Sung; Jennifer W Mack; Mia K Waldron; Catriona Mowbray; Diana Palma; Pamela S Hinds
Journal:  J Pain Symptom Manage       Date:  2017-01-03       Impact factor: 3.612

Review 5.  Pediatric Palliative Care in Oncology.

Authors:  Jennifer Snaman; Sarah McCarthy; Lori Wiener; Joanne Wolfe
Journal:  J Clin Oncol       Date:  2020-02-05       Impact factor: 44.544

Review 6.  Child and adolescent self-report symptom measurement in pediatric oncology research: a systematic literature review.

Authors:  Laura C Pinheiro; Molly McFatrich; Nicole Lucas; Jennifer S Walker; Janice S Withycombe; Pamela S Hinds; Lillian Sung; Deborah Tomlinson; David R Freyer; Jennifer W Mack; Justin N Baker; Bryce B Reeve
Journal:  Qual Life Res       Date:  2017-09-06       Impact factor: 4.147

7.  The association of age, literacy, and race on completing patient-reported outcome measures in pediatric oncology.

Authors:  Janice S Withycombe; Molly McFatrich; Laura Pinheiro; Pamela S Hinds; Frank G Keller; Justin N Baker; Jenny W Mack; Lillian Sung; Mia K Waldron; Bryce B Reeve
Journal:  Qual Life Res       Date:  2019-01-17       Impact factor: 4.147

8.  Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.

Authors:  Bryce B Reeve; Molly McFatrich; Jennifer W Mack; Scott H Maurer; Shana S Jacobs; David R Freyer; Janice S Withycombe; Justin N Baker; Sharon M Castellino; Li Lin; Nicole R Lucas; Pamela S Hinds
Journal:  J Natl Cancer Inst       Date:  2020-11-01       Impact factor: 13.506

Review 9.  Consensus Recommendations From the Children's Oncology Group Nursing Discipline's State of the Science Symposium: Symptom Assessment During Childhood Cancer Treatment.

Authors:  Janice S Withycombe; Maureen Haugen; Sue Zupanec; Catherine F Macpherson; Wendy Landier
Journal:  J Pediatr Oncol Nurs       Date:  2019 Jul/Aug       Impact factor: 1.636

10.  Symptom Monitoring in Pediatric Oncology Using Patient-Reported Outcomes: Why, How, and Where Next.

Authors:  Allison Barz Leahy; Chris Feudtner; Ethan Basch
Journal:  Patient       Date:  2018-04       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.